Radiopharm Theranostics Limited (RADX)

NASDAQ: RADX · Real-Time Price · USD

4.270

-0.080 (-1.84%)

At close: Apr 30, 2026, 4:00 PM EDT

4.290

+0.020 (0.47%)

After-hours: Apr 30, 2026, 7:54 PM EDT

Radiopharm Theranostics Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Market Cap	48	37	-	-	-	-
Market Cap Growth	42.68%	-	-	-	-	-
Enterprise Value	22.27	16.19	0	0	0	0
Last Close Price	4.27	4.64	-	-	-	-
PE Ratio	-	-1.34	-	-	-	-
PS Ratio	4.46	15.32	-	-	-	-
PB Ratio	1.45	1.24	-	-	-	-
P/TBV Ratio	-	0.72	-	-	-	-
P/FCF Ratio	-	-1.52	-	-	-	-
P/OCF Ratio	-	-1.52	-	-	-	-
EV/Sales Ratio	2.05	6.78	-	-	-	-
EV/EBITDA Ratio	-	-0.69	-	-	-	-
EV/EBIT Ratio	-	-0.64	-	-	-	-
EV/FCF Ratio	-	-0.67	-	-	-	-
Net Debt / Equity Ratio	-	-0.65	-0.66	-0.26	-0.43	-
Net Debt / EBITDA Ratio	-	0.82	0.42	0.38	1.50	-
Net Debt / FCF Ratio	-	0.80	0.81	0.50	2.72	-
Asset Turnover	-	0.05	0.00	0.00	0	-
Quick Ratio	-	2.65	1.11	1.22	3.43	-
Current Ratio	-	2.67	1.30	1.23	3.46	-
Return on Equity (ROE)	-	-109.20%	-131.49%	-63.77%	-96.63%	-
Return on Assets (ROA)	-	-48.29%	-64.37%	-43.61%	-50.51%	-
Return on Invested Capital (ROIC)	-	-85.27%	-94.57%	-61.65%	-77.76%	-
Return on Capital Employed (ROCE)	-	-60.59%	-81.27%	-50.26%	-55.70%	-
Earnings Yield	-64.21%	-74.79%	-	-	-	-
FCF Yield	-55.21%	-65.84%	-	-	-	-
Buyback Yield / Dilution	-114.63%	-438.49%	-26.36%	-68.74%	-20138366.67%	-
Total Shareholder Return	-114.63%	-438.49%	-26.36%	-68.74%	-20138366.67%	-

Updated Mar 31, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q